Mitchall G. Clark

General Counsel at AADI BIOSCIENCE, INC.

63 year

Health Technology

Consumer Services

Technology Services

Profile

Mitchall G.
Clark is a Senior VP-Regulatory Affairs & Quality Assurance at Aadi Bioscience, Inc. He previously held positions as Senior Director-Regulatory Affairs at Faulding, Inc. and American Bioscience, Inc., Vice President-Regulatory Affairs at APP Pharmaceuticals, Inc., Senior Vice President-Global Regulatory Affairs at Abraxis BioScience, Inc., Senior Vice President-Regulatory Affairs at Celgene Corp., NantWorks LLC, and Abraxis BioScience, Inc., Senior Vice President-Regulatory Affairs & Quality at NantPharma LLC, and Chief Regulatory & Quality Assurance Officer at Atara Biotherapeutics, Inc. He also worked as a Principal at Lindum Pharmaceutical Services Corp.
Mr. Clark received an undergraduate degree from The University of Nottingham.

Mitchall G. Clark active positions

Companies	Position	Start
AADI BIOSCIENCE, INC.	General Counsel	2018-07-31

All active positions of Mitchall G. Clark

Former positions of Mitchall G. Clark

Companies	Position	End
Lindum Pharmaceutical Services Corp.	Corporate Officer/Principal	2014-02-28
NantPharma LLC NantPharma LLC Pharmaceuticals: MajorHealth Technology Part of NantWorks LLC, NantPharma LLC is a company that manufactures injectable pharmaceutical products. The company is based in Lincolnshire, IL.	General Counsel	2013-05-31
CELGENE	General Counsel	2011-05-31
Abraxis BioScience, Inc. Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA.	General Counsel	2007-10-31
Abraxis BioScience, Inc. /Old/ Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL	General Counsel	2006-03-31

See the detail of Mitchall G. Clark's experience

Training of Mitchall G. Clark

The University of Nottingham

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mitchall G. Clark's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
ATARA BIOTHERAPEUTICS, INC.	Health Technology
AADI BIOSCIENCE, INC.	Health Technology

Private companies	10
Abraxis BioScience, Inc. /Old/ Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL	Health Technology
APP Pharmaceuticals, Inc. APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA.	Health Technology
American Bioscience, Inc.	Health Technology
Faulding, Inc.	Health Technology
Abraxis BioScience, Inc. Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA.	Health Technology
DNIB Unwind, Inc. DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA.	Health Technology
NantPharma LLC NantPharma LLC Pharmaceuticals: MajorHealth Technology Part of NantWorks LLC, NantPharma LLC is a company that manufactures injectable pharmaceutical products. The company is based in Lincolnshire, IL.	Health Technology
Lindum Pharmaceutical Services Corp.
Celgene Corp. Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.	Health Technology
NantWorks LLC NantWorks LLC Information Technology ServicesTechnology Services NantWorks LLC develops technology based semiconductor and advanced networks for healthcare improvements. Its solution is for life threatening diseases such as cancer, infectious diseases and Alzheimer’s. The company was founded by Patrick Soon-Shiong in September 2011 and is headquartered in Culver City, CA.	Technology Services